Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Adverse Drug Reactions Common in CKD
Bavencio Approved for First-Line Urothelial Carcinoma Maintenance Treatment
Allopurinol Does Not Affect eGFR in Chronic Kidney Disease
FDA Grants Orphan Drug Status to Mitapivat for Thalassemia
Rituximab Superior for Preventing ANCA-Associated Vasculitis Relapse
Lumasiran Granted Priority Review for Primary Hyperoxaluria Type 1
Ferriprox Twice-a-Day Tablet Dosing Approved for Transfusional Iron Overload Due to Thalassemia Syndromes
Sutimlimab Under Review for Hemolysis in Cold Agglutinin Disease
New Dosage Options of Potassium Phosphates Injection Available From Fresenius Kabi
Vadadustat Noninferior to Darbepoetin Alfa for Anemia in Patients With Dialysis-Dependent CKD
New Dosing Schedule Approved for All Keytruda Indications
Lokelma Labeling Updated With Dosing for Hyperkalemia in Dialysis-Dependent ESRD
Patient’s Death Leads to Lawsuit After Physician Fails to Check Creatinine Level Before Infusing Drug
FDA Approves Reblozyl for Anemia in Patients With Myelodysplastic Syndromes
Dapagliflozin CKD Trial Stopped Early Due to “Overwhelming Efficacy”
Triferic AVNU Approved for Iron Replacement and Hemoglobin Maintenance in Dialysis Patients
Interleukin-1β Inhibition Linked to Reduced Incidence of Anemia
Update for SGLT2 Inhibitors: Temporary Discontinuation Prior to Surgery Recommended
